Cargando…
Formulary Submissions: Value Claims, Protocols and Outcomes Based Contracting in Rare Disease
Outcomes based payments contracting is in its infancy. The increased attention being given to rare disease place a premium on the ability to engage with payers to ensure that there is an analytical framework relevant to value claims contracting. Rare disease is not, of course, alone; many other chro...
Autor principal: | Langley, Paul C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Minnesota Libraries Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815865/ https://www.ncbi.nlm.nih.gov/pubmed/36627905 http://dx.doi.org/10.24926/iip.v13i3.5020 |
Ejemplares similares
-
Value Assessment, Real World Evidence and Fundamental Measurement: Version 3.0 of the Minnesota Formulary Submission Guidelines
por: Langley, Paul C
Publicado: (2020) -
Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims
por: Langley, Paul C
Publicado: (2021) -
Blockchains, Formulary Evaluations and Health Technology Assessment
por: Langley, Paul C, et al.
Publicado: (2018) -
Evolution of the AMCP Format for Formulary Submissions
por: Watkins, John B., et al.
Publicado: (2020) -
AMCP Format for Formulary Submissions, Version 4.0
por: Pannier, Alan, et al.
Publicado: (2016)